Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study

Development of Machine Learning Model to Predict the 5-Year Risk of Starting Biologic Agents in Patients with Inflammatory Bowel Disease (IBD): K-CDM Network Study

Background: The incidence and global burden of inflammatory bowel disease (IBD) have steadily increased in the past few decades. Improved methods to stratify risk and predict disease-related outcomes are required for IBD. Aim: The aim of this study was to develop and validate a machine learning (ML)...

Full description

Bibliographic Details
Main Authors: Youn I Choi, Sung Jin Park, Jun-Won Chung, Kyoung Oh Kim, Jae Hee Cho, Young Jae Kim, Kang Yoon Lee, Kwang Gi Kim, Dong Kyun Park, Yoon Jae Kim
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
machine-learning
IBD
UC
CD
Online Access:https://www.mdpi.com/2077-0383/9/11/3427

Internet

https://www.mdpi.com/2077-0383/9/11/3427

Similar Items